Caffeine use disorder: A widespread health problem that needs more attention
Caffeine is the most widely used drug, but little is known about helping those who depend on it. “I’m a zombie without my morning coffee.” “My blood type… read more.
Caffeine is the most widely used drug, but little is known about helping those who depend on it. “I’m a zombie without my morning coffee.” “My blood type… read more.
New interim analysis study findings presented for the first time today at the 55th American Society of Hematology (ASH) Annual Meeting in New Orleans suggest bendamustine and rituximab… read more.
For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to… read more.
by Bruce Sylvester – Fibromyalgia syndrome (FMS) patients with low vitamin D can reduce pain by taking supplements, and possibly lower the costs of other drug and non-drug… read more.
For some, it’s the tradition of steeping tealeaves to brew the perfect cup of tea. For others, it’s the morning shuffle to a coffee maker for a hot… read more.
Findings also show that patients report pain relief even when they know they are receiving a placebo.
PET molecular imaging of the brain reveals that ketamine may act as an antidepressant by boosting serotonin activity in brain areas involved in motivation.
by Bruce Sylvester – Prophylactic use of the breast cancer drug anastrozole for five years reduced by 53% the development of breast cancer in post-menopausal women at high… read more.
by Bruce Sylvester – Gabapentin, a treatment for epilepsy and neuropathic pain, appears to be safe and effective for treating alcohol dependence, researchers reported in JAMA Internal Medicine… read more.
by Bruce Sylvester – An investigative drug could offer the first safe and effective treatment for psychotic symptoms that affect about half of people with Parkinson’s disease, researchers… read more.
by Bruce Sylvester – Diflunisal, a generic anti-inflammatory drug, appears to reduce neurological decline and preserve quality-of-life in patients with familial transthyretin amyloidosis (ATTR).
Patients in a vegetative state are awake, breathe on their own, and seem to go in and out of sleep. But they do not respond to what is… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.